Company intelligence / Profile preview

Centenarian Fund

Ownership: Private
Development stage: Other

Overview

Centenarian Fund is an active investment firm focused on supporting early-stage and growth-stage biotechnology and healthcare companies that are developing therapies and interventions for healthy longevity. Its portfolio spans consumer health/wellness startups as well as therapeutics addressing hallmarks of aging such as genomic instability and cellular senescence. The fund’s team brings decades of drug development experience to support founders in translating science into clinical impact.

Therapeutic areas: OtherOphthalmology
Modalities: Small moleculeBiologicSupplementsLifestyle intervention
Industry: Investors

Beyond the preview

Go deeper on Centenarian Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centenarian Fund.

Explore the full profile